Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Europe Hospital Acquired Disease Testing Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The Europe hospital acquired disease testing market exhibited robust growth during 2015-2020. Looking forward, IMARC Group expects the market to continue its robust growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Hospital-acquired diseases (HAD), or nosocomial infections, are illnesses caused by exposure to viral, bacterial and fungal pathogens during hospital visits. Some commonly known infections are catheter-associated urinary tract infections (CAUTI), surgical site infections (SSI), hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP).  The various tests used to diagnose these infections are complete blood count (CBC) test, erythrocyte sedimentation rate (ESR) test, and urinalysis, cultures of the infected area, blood, urine and other body fluids. Other diagnostic tests, such as antimicrobial susceptibility testing (AST), are conducted for the testing of tuberculosis.

The increasing prevalence of hospital-acquired infections across Europe is one of the key factors driving the market. Furthermore, various technological advancements, such as the development of innovative diagnostic instruments and technologies, including flow cytometry, mass spectrometry and near-infrared spectroscopy, are providing a boost to the market growth. Additionally, the growing awareness regarding HADs and the available treatment options among patients, along with extensive research and development (R&D) in the field of medical sciences, are contributing to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Europe hospital acquired disease testing market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on indication.

Breakup by Indication:

  • UTI (Urinary Tract Infection)
  • SSI (Surgical Site Infection)
  • Pneumonia
  • Bloodstream Infections
  • MRSA (Methicillin-Resistant Staphylococcus Aureus)
  • Others
     

Breakup by Country:

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Indication, Country
Countries Covered Germany, France, United Kingdom, Italy, Spain, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option

Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the Europe hospital acquired disease testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Europe hospital acquired disease testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the indication?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the Europe hospital acquired disease testing market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology 

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Europe Hospital Acquired Disease Testing Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Indication
    6.1    UTI (Urinary Tract Infection)
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    SSI (Surgical Site Infection)
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Pneumonia
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Bloodstream Infections
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    MRSA (Methicillin-Resistant Staphylococcus Aureus)
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Country
    7.1    Germany
        7.1.1 Market Trends
        7.1.2 Market Breakup by Indication
        7.1.3 Market Forecast
    7.2    France
        7.2.1 Market Trends
        7.2.2 Market Breakup by Indication
        7.2.3 Market Forecast
    7.3    United Kingdom
        7.3.1 Market Trends
        7.3.2 Market Breakup by Indication
        7.3.3 Market Forecast
    7.4    Italy
        7.4.1 Market Trends
        7.4.2 Market Breakup by Indication
        7.4.3 Market Forecast
    7.5    Spain
        7.5.1 Market Trends
        7.5.2 Market Breakup by Indication
        7.5.3 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Breakup by Indication
        7.6.3 Market Forecast
8    SWOT Analysis
    8.1    Overview
    8.2    Strengths
    8.3    Weaknesses
    8.4    Opportunities
    8.5    Threats
9    Value Chain Analysis
10    Porters Five Forces Analysis

    10.1    Overview
    10.2    Bargaining Power of Buyers
    10.3    Bargaining Power of Suppliers
    10.4    Degree of Competition
    10.5    Threat of New Entrants
    10.6    Threat of Substitutes
11    Policy and Regulatory Landscape
12    Competitive Landscape

    12.1    Market Structure
    12.2    Key Players
    12.3    Profiles of Key Players

List of Figures

Figure 1: Europe: Hospital Acquired Disease Testing Market: Major Drivers and Challenges
Figure 2: Europe: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015-2020
Figure 3: Europe: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Europe: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 5: Europe: Hospital Acquired Disease Testing Market: Breakup by Country (in %), 2020
Figure 6: Europe: Hospital Acquired Disease Testing (Urinary Tract Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 7: Europe: Hospital Acquired Disease Testing (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 8: Europe: Hospital Acquired Disease Testing (Surgical Site Infection) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Europe: Hospital Acquired Disease Testing (Surgical Site Infection) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Europe: Hospital Acquired Disease Testing (Pneumonia) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Europe: Hospital Acquired Disease Testing (Pneumonia) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Europe: Hospital Acquired Disease Testing (Bloodstream Infections) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Europe: Hospital Acquired Disease Testing (Bloodstream Infections) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Europe: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Europe: Hospital Acquired Disease Testing (Methicillin-Resistant Staphylococcus Aureus) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Europe: Hospital Acquired Disease Testing (Other Indications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Europe: Hospital Acquired Disease Testing (Other Indications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Germany: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Germany: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 20: Germany: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: France: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: France: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 23: France: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: United Kingdom: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: United Kingdom: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 26: United Kingdom: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Italy: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Italy: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 29: Italy: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026 
Figure 30: Spain: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Spain: Hospital Acquired Disease Testing Market: Breakup by Indication (in %), 2020
Figure 32: Spain: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Others: Hospital Acquired Disease Testing Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Others: Hospital Acquired Disease Testing Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Europe: Hospital Acquired Disease Testing Industry: SWOT Analysis
Figure 36: Europe: Hospital Acquired Disease Testing Industry: Value Chain Analysis
Figure 37: Europe: Hospital Acquired Disease Testing Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Europe: Hospital Acquired Disease Testing Market: Key Industry Highlights, 2020 and 2026
Table 2: Europe: Hospital Acquired Disease Testing Market Forecast: Breakup by Indication (in Million US$), 2021-2026
Table 3: Europe: Hospital Acquired Disease Testing Market Forecast: Breakup by Country (in Million US$), 2021-2026
Table 4: Europe: Hospital Acquired Disease Testing Market: Competitive Structure
Table 5: Europe: Hospital Acquired Disease Testing Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links